These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 27637382)
21. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation. Ma F; Du H Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380 [TBL] [Abstract][Full Text] [Related]
27. Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands. Łażewska D; Jończyk J; Bajda M; Szałaj N; Więckowska A; Panek D; Moore C; Kuder K; Malawska B; Kieć-Kononowicz K Bioorg Med Chem Lett; 2016 Aug; 26(16):4140-5. PubMed ID: 27445168 [TBL] [Abstract][Full Text] [Related]
28. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore. Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855 [TBL] [Abstract][Full Text] [Related]
29. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo. Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744 [TBL] [Abstract][Full Text] [Related]
31. Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity. Bosak A; Knežević A; Gazić Smilović I; Šinko G; Kovarik Z J Enzyme Inhib Med Chem; 2017 Dec; 32(1):789-797. PubMed ID: 28573890 [TBL] [Abstract][Full Text] [Related]
32. Effects of structural modifications on the metal binding, anti-amyloid activity, and cholinesterase inhibitory activity of chalcones. Fosso MY; LeVine H; Green KD; Tsodikov OV; Garneau-Tsodikova S Org Biomol Chem; 2015 Sep; 13(36):9418-26. PubMed ID: 26248214 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives. Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279 [TBL] [Abstract][Full Text] [Related]
35. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid. Geula C; Greenberg BD; Mesulam MM Brain Res; 1994 May; 644(2):327-30. PubMed ID: 8050043 [TBL] [Abstract][Full Text] [Related]
36. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283 [TBL] [Abstract][Full Text] [Related]
37. Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems. Darvesh S; Macdonald IR; Martin E Bioorg Med Chem Lett; 2013 Jul; 23(13):3822-5. PubMed ID: 23707254 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors. Kia Y; Osman H; Suresh Kumar R; Basiri A; Murugaiyah V Bioorg Med Chem Lett; 2014 Apr; 24(7):1815-9. PubMed ID: 24594354 [TBL] [Abstract][Full Text] [Related]
39. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents. Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241 [TBL] [Abstract][Full Text] [Related]
40. A review on cholinesterase inhibitors for Alzheimer's disease. Anand P; Singh B Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]